title: Oral cibenzoline reduces postoperative atrial fibrillation in coronary artery bypass grafting.
abstract: OBJECTIVE
  The objective of the present study was to investigate the effectiveness of postoperative oral administration of cibenzoline for the prevention of atrial fibrillation (AF) in coronary artery bypass grafting (CABG).
  
  
  METHODS
  A total of 39 patients who underwent isolated CABG from September 2000 to February 2001 and who took oral cibenzoline (300 mg per day for 10 days beginning immediately after surgery) were compared to 59 patients who underwent surgery in our department 8 months prior to the study and who did not take cibenzoline for incidence of postoperative AF. Exclusion criteria encompassed age (>80 years), low ejection fraction (<30%), high serum creatinine level (>2.0 mg/dL), and history of supraventricular arrhythmia with or without treatment by anti-arrhythmic drugs.
  
  
  RESULTS
  Postoperative AF occurred in 2 patients in the cibenzoline group (2/35, 5.7%) and 20 patients in the control group (20/59, 33.9%). There were significant differences in the incidence of postoperative AF (p = 0.002). Multivariate analysis revealed that the administration of cibenzoline reduced the incidence of AF significantly, and that a large number of bypass grafts significantly contributed to postoperative AF in CABG. The number of bypass grafts was significantly larger in the cibenzoline group, indicating that cibenzoline administration significantly suppresses the incidence of AF after CABG in high-risk patients.
  
  
  CONCLUSIONS
  Postoperative administration of oral cibenzoline for 10 days is one effective method for the prevention of AF after CABG.
authors.affiliation: Department of Cardiothoracic Surgery, Tokyo Medical and Dental University Graduate School of Medicine, Tokyo, Japan.
authors.forename: Kazuyuki
authors.initials: K
authors.lastname: Kuriu
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Tanaka
authors.forename: Kenzo
authors.initials: K
authors.lastname: Hirao
authors.forename: Satoru
authors.initials: S
authors.lastname: Makita
authors.forename: Fusahiko
authors.initials: F
authors.lastname: Ito
authors.forename: Tomohiro
authors.initials: T
authors.lastname: Mizuno
authors.forename: Noriyuki
authors.initials: N
authors.lastname: Tabuchi
authors.forename: Hirokuni
authors.initials: H
authors.lastname: Arai
authors.forename: Makoto
authors.initials: M
authors.lastname: Sunamori
mesh_terms: D000284:Administration, Oral; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D001026:Coronary Artery Bypass / Q000009:adverse effects*; D003324:Coronary Artery Disease / Q000453:epidemiology / Q000601:surgery*; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D016896:Treatment Outcome
chemical_list: D000889:Anti-Arrhythmia Agents; D007093:Imidazoles; C032151:cifenline
references.citation: Chest. 2002 Apr;121(4):1203-10
references.pmid: 11948054
references.citation: Crit Care Med. 1993 Oct;21(10):1474-8
references.pmid: 8403955
references.citation: Drugs. 1992 May;43(5):734-59
references.pmid: 1379150
references.citation: JAMA. 1996 Jul 24-31;276(4):300-6
references.pmid: 8656542
references.citation: N Engl J Med. 1997 Dec 18;337(25):1785-91
references.pmid: 9400034
references.citation: Ann Thorac Surg. 1993 Sep;56(3):539-49
references.pmid: 8379728
references.citation: Eur Heart J. 1984 Feb;5(2):108-14
references.pmid: 6723683
references.citation: Prog Cardiovasc Dis. 1989 Mar-Apr;31(5):367-78
references.pmid: 2646657
references.citation: Ann Thorac Surg. 1997 Oct;64(4):1113-9
references.pmid: 9354537
references.citation: J Thorac Cardiovasc Surg. 1991 Jan;101(1):56-65
references.pmid: 1986170
references.citation: Transplant Proc. 1993 Feb;25(1 Pt 2):1613-7
references.pmid: 8442211
references.citation: Jpn Circ J. 1999 Jan;63(1):1-12
references.pmid: 10084381
references.citation: Am Heart J. 1992 May;123(5):1225-8
references.pmid: 1575138
references.citation: Am J Cardiol. 1989 May 1;63(15):1058-64
references.pmid: 2495710
references.citation: J Cardiovasc Pharmacol. 1999 Jul;34(1):53-9
references.pmid: 10413067
references.citation: J Cardiovasc Pharmacol. 1989 Jul;14(1):88-95
references.pmid: 2475722
references.citation: Chest. 1993 May;103(5):1515-9
references.pmid: 8486036
references.citation: Eur J Cardiothorac Surg. 1987;1(3):165-8
references.pmid: 3272807
references.citation: Circulation. 1996 Aug 1;94(3):390-7
references.pmid: 8759081
references.citation: J Am Coll Cardiol. 1999 Aug;34(2):334-9
references.pmid: 10440141
references.citation: Circulation. 1991 Nov;84(5 Suppl):III236-44
references.pmid: 1682069
references.citation: J Thorac Cardiovasc Surg. 1990 Sep;100(3):338-42
references.pmid: 2391970
references.citation: Circulation. 2001 Oct 23;104(17):2118-50
references.pmid: 11673357
references.citation: Eur Heart J. 1994 Sep;15(9):1274-8
references.pmid: 7982430
references.citation: Ann Thorac Surg. 1985 Apr;39(4):336-9
references.pmid: 3885884
references.citation: Am J Cardiol. 1990 Mar 1;65(9):628-32
references.pmid: 2309633
references.citation: Heart. 2003 Oct;89(10):1134-7
references.pmid: 12975397